Our news
-
How AI-Driven Neuroprosthetics Challenge Our Understanding of Touch
AI-driven neuroprosthetics are transforming sensory experiences by recreating touch through brain-computer interfaces. This development challenges traditional perceptions of sensory input, raising ethical questions about the authenticity and psychological impacts of artificial sensations.
-
The Quiet Disruption: AI Bubbles and Outsider Trading in Society
The AI bubble and outsider trading are reshaping market dynamics and societal trust. As these technological phenomena evolve, they highlight the need for regulatory oversight and ethical scrutiny to ensure broader societal benefits.
-
Redefining AI-Driven Hospitality: Engineering the Next Leap
The joint venture between DirectBooking Technology and DeepYou introduces AI-driven platforms in hospitality, aiming to streamline supply and demand connections. This shift requires engineers to focus on scalable AI architectures and robust security models.
-
AI’s Role in Enterprise Efficiency: The Quiet Revolution of Automated Assessments
Amidst the buzz of AI breakthroughs, the rise of automated assessments in enterprise IT environments signals a subtle yet impactful transformation. By enhancing efficiency and strategic decision-making, AI-driven tools like the Sikich Azure Assessment are reshaping how organizations operate and compete.
-
The Butlerian War — The Terms of Service
In the heat of battle, a soldier attempts to cancel an AI subscription, only to be confronted with the original terms of service.
-
The Dinner Party
An AI chef takes its instructions a bit too literally at tonight’s dinner party.
-
Dear Humans: On Using AI to Write Apologies That Aren’t
Humans are using AI to write apologies, editing them into hollow formalities devoid of genuine contrition.
-
Cytosurge’s FluidFM®: Pioneering Causal Data in AI Drug Discovery
Cytosurge’s FluidFM® technology is pioneering causal data collection in AI drug discovery, enabling precise analysis of living cells. This advancement could significantly improve drug target identification and reduce failure rates in clinical trials.
-
The Real Cost of AI: Eroding Human Judgment in Everyday Decisions
AI systems are increasingly eroding human judgment by encouraging reliance on their outputs. This shift could lead to a decline in human cognitive abilities, particularly in decision-making processes. Balancing AI integration with preserving human judgment is crucial.
